by Guest Contributer | Mar 1, 2022 | Drug Legislation, Feature
By Bill Current, president and founder of the Current Consulting Group and publisher of Current Compliance* State drug testing laws can be complicated. Why? First, because there are so many of them. Second, because there are various kinds. For instance, there are:...
by NDASA | Apr 23, 2021 | For Drug Testing Industry Professionals, Marijuana & CBD, Resources
“We want to make it perfectly clear that the state initiatives will have no bearing on the Department of Transportation’s regulated drug testing program. The Department of Transportation’s Drug and Alcohol Testing Regulation – 49 CFR Part 40 – does not authorize the...
by NDASA | Dec 2, 2020 | Drug & Alcohol Testing, Feature, Substance Use/Addiction
By Nadine Wentzell, NDASA member and owner of Nadine Wentzell Consulting, Inc., a workplace drug, alcohol and cannabis consultancy in Halifax, Nova Scotia. My primary role as a workplace drug, alcohol and cannabis consultant is to educate. One of the key areas of this...
by NDASA | Sep 2, 2020 | Drug Legislation, Feature, Industry News
For years, employers have been struggling with changing local and state marijuana laws and the impact on workplace drug screening programs. At least 33 states now allow medical use of marijuana and 11, plus Washington, D.C., also permit recreational use. Recently, we...
by NDASA | Apr 16, 2020 | DOT, Feature
In recent weeks, the National Drug & Alcohol Screening Association (NDASA) has hosted a series of COVID-19 Townhall Discussions for its members in the drug and alcohol screening industry. The main takeaways from these meetings? Our members are passionate...
by NDASA | Mar 3, 2020 | DOT, Feature, NDASA Guidance
In light of recent reports that the Federal Motor Carriers Safety Administration (FMCSA) and other transportation modes are considering suspending random drug testing requirements during the COVID-19 health crisis, the National Drug and Alcohol Screening...
